+ All Categories
Home > Documents > Public Health Genomics: future paradigm shift for YHC?

Public Health Genomics: future paradigm shift for YHC?

Date post: 18-Jan-2016
Category:
Upload: malha
View: 31 times
Download: 0 times
Share this document with a friend
Description:
Public Health Genomics: future paradigm shift for YHC?. Prof. dr. Frans J.M. Feron Department of Social Medicine Faculty of Health Medicine and Life Sciences Maastricht University [email protected]. Public Health Genomics:. - PowerPoint PPT Presentation
Popular Tags:
24
Public Health Genomics: Public Health Genomics: future paradigm shift for YHC? future paradigm shift for YHC? Prof. dr. Frans J.M. Feron Prof. dr. Frans J.M. Feron Department of Social Medicine Department of Social Medicine Faculty of Health Medicine and Life Sciences Faculty of Health Medicine and Life Sciences Maastricht University Maastricht University [email protected] [email protected]
Transcript
Page 1: Public Health Genomics: future paradigm shift for YHC?

Public Health Genomics:Public Health Genomics:

future paradigm shift for YHC?future paradigm shift for YHC?

Prof. dr. Frans J.M. FeronProf. dr. Frans J.M. FeronDepartment of Social MedicineDepartment of Social Medicine

Faculty of Health Medicine and Life SciencesFaculty of Health Medicine and Life Sciences

Maastricht UniversityMaastricht University

[email protected]@maastrichtuniversity.nl

Page 2: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 22

Public Health Genomics:

• …the use of genomics information to benefit Public Health

• …an emerging field of study that assesses the impact of genes and their interaction with behavior, diet and the environment on the population’s health

• …18.800.000 hits on ‘Genomics’ by Google

• …1.320.000 hits on ‘Public Health Genomics’ by Google

• …798.385 ‘genomic’ hits by PubMed

Page 3: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 33

The main focus of Child & Youth Health Care:

• …health - growth – development

• …the interaction between the genetically biological vulnerable child and the environment where relevant to health – growth - development

Page 4: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 4

The Health Field ConceptMarc Lalonde, 1974

Page 5: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 5

The Health Field ConceptMarc Lalonde, 1974

Page 6: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 6

Bio-ecological transactional model

Page 7: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 7

Bio-ecological transactional model

Page 8: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 88

Biopsychosocial model

Ref: Brunner & Marmot, 2006

Page 9: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 99

Biopsychosocial model

Ref: Brunner & Marmot, 2006

Page 10: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 10

Genomics prospective health care:

Ref: Snyderman R. The role of genomics in enabling prospective health care. In: Willard H, Ginsburg GS, eds. Genomic and personalized medicine. Durham, NC: Elsevier, 2009:378–85.

Page 11: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 1111

Vanderbilt doing long-term study of child healthDec. 3, 2010, 3:03 a.m. CSTAssociated Press

NASHVILLE, Tenn. (AP) — Vanderbilt University Medical Center in Nashville and others have begun a major long-term study of child health in the United States.The National Children's Study will examine how environment, behavior and genetics impact children's health, development and growth. It will track 100,000 children from before birth to age 21.

Page 12: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 1212

Vanderbilt doing long-term study of child healthDec. 3, 2010, 3:03 a.m. CSTAssociated Press

NASHVILLE, Tenn. (AP) — Vanderbilt University Medical Center in Nashville and others have begun a major long-term study of child health in the United States.The National Children's Study will examine how environment, behavior and genetics impact children's health, development and growth. It will track 100,000 children from before birth to age 21.

Page 13: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 13

“Classic” example: newborn screeningAandoening Per jaar (NL)

Adrenogenitaal Syndroom (AGS) 15-20

Biotinidase deficiëntie (BIO) 2

Congenitale hypothyreoïdie (CH) 70-90

Galactosemie (GAL) 6

Glutaar acidurie type I (GA-I) 1

HMG-CoA-lyase deficiëntie (HMG) ?

Homocystinurie (HCY) 1-2

Isovaleriaan acidemie (IVA) 3

Long-chain hydroxyacylCoA dehydrogenase deficiëntie (LCHAD) ?

Maple syrup urine disease (MSUD) 1

Medium-chain acylCoA dehydrogenase deficiëntie (MCAD) 15-17

3-methylcrotonyl-CoAcarboxylase deficiëntie (3-MCC) (?)

Multiple CoA carboxylase deficiëntie (MCD) ?

Phenylketonurie (PKU) 10-15

Sikkelcelziekte (SZ) 40-60

Thalassemie 25-50

Tyrosinemie type I (TYR-I) 2

Very long-chain acylCoA dehydrogenase deficiëntie (VLCAD) ?

Cystic Fibrosis (CF) 50

Totaal per jaar op ca 180.000 240-320

Page 14: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 14

“Classic” example: newborn screeningAandoening Per jaar (NL)

Adrenogenitaal Syndroom (AGS) 15-20

Biotinidase deficiëntie (BIO) 2

Congenitale hypothyreoïdie (CH) 70-90

Galactosemie (GAL) 6

Glutaar acidurie type I (GA-I) 1

HMG-CoA-lyase deficiëntie (HMG) ?

Homocystinurie (HCY) 1-2

Isovaleriaan acidemie (IVA) 3

Long-chain hydroxyacylCoA dehydrogenase deficiëntie (LCHAD) ?

Maple syrup urine disease (MSUD) 1

Medium-chain acylCoA dehydrogenase deficiëntie (MCAD) 15-17

3-methylcrotonyl-CoAcarboxylase deficiëntie (3-MCC) (?)

Multiple CoA carboxylase deficiëntie (MCD) ?

Phenylketonurie (PKU) 10-15

Sikkelcelziekte (SZ) 40-60

Thalassemie 25-50

Tyrosinemie type I (TYR-I) 2

Very long-chain acylCoA dehydrogenase deficiëntie (VLCAD) ?

Cystic Fibrosis (CF) 50

Totaal per jaar op ca 180.000 240-320

Page 15: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 1515

Example: ADHD

Russell A. Barkley, 2006

The totality of evidence indicates that neurological and genetic factors play a substantial role in the origins and the expression of this disorder

Page 16: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 1616

ADHD: genetic contribution is a “fact in the bag”

Evidence-based genetic association with ADHD:

DRD4 - dopamine D4 receptor DRD5 - dopamine D5 receptor DAT - dopamine transporter gen DBH - dopamine β-hydroxylase 5-HTT - serotonin transporter gen HTR1B - serotonin receptor gen SNAP-25 - synaptosomal-associated protein 25

Faraone et al, Biol Psychiatry, 2005;57:1313

Page 17: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 17

Example: schisis

Page 18: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 18

Example: early life stress

Page 19: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 19

Example: Child maltreatment

Ref: Nature Neuroscience 2009, vol. 12 no. 8

Page 20: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 20

Paradigm shift:

Page 21: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 21

Page 22: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 2222

Challenges and benefits PH-Genomics for child and youth health care…

• To develop and make family history tools available for prevention

• To understand health effects of gene-environment interaction via public health investigations

• To improve quality of life for our children & families• To reduce health costs through early detection and

intervention• To improve long-term health outcomes in a life course

perspective, with children transitioning to healthy and productive adults

Child Health Genomics Working Group, Canada 2008

Page 23: Public Health Genomics: future paradigm shift for YHC?

FHML - Social Medicine – Prof. dr. F. Feron slide 23

On behalf of all children…

…I wish you lots of (genomics-)inspiration for the future!

Page 24: Public Health Genomics: future paradigm shift for YHC?

Thank you for your attentionThank you for your attention

Maastricht, 2011 - Prof. dr. Frans J.M. Feron


Recommended